BioCryst Pharmaceuticals
The Director, Clinical Development Sciences leads the delivery of high-quality data from multiple sources while supporting the management of global development programs for product candidates across all study phases. This role involves leading multi-disciplinary clinical development teams, ensuring scientific and regulatory standards, and contributing to clinical strategy and regulatory submissions. The position requires expertise in clinical trial design, data analysis, and cross-functional team management to drive successful drug development programs.
Headquarters
Durham, North Carolina, United States
Company Size
501-1000 employees
Founded
1986
BioCryst Pharmaceuticals is a global biotech company with over three decades of experience in drug discovery, development, and commercialization, specializing in rare disease therapeutics. Founded in 1986, the company focuses on hereditary angioedema (HAE) and other rare diseases, delivering first-in-class or best-in-class oral small-molecule and injectable protein therapeutics. BioCryst uses a novel, structure-guided approach blending traditional biology and medicinal chemistry with advanced technologies to develop medicines for underserved patient communities worldwide.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for BioCryst Pharmaceuticals.